Frovocimab (Anti-PCSK9)
Frovocimab (Anti-PCSK9) (A2876-GRP)
Products
Description
Frovocimab (Anti-PCSK9) is a humanized IgG4 monoclonal antibody that neutralizes proprotein convertase subtilisin-kexin type 9 (PCSK9). MW: 146.88 KD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2876 |
| Target | PCSK9 |